Linked Life Data

11754592

Source:http://linkedlifedata.com/resource/pubmed/id/11754592

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11754592rdf:typepubmed:Citationlld:pubmed
pubmed-article:11754592lifeskim:mentionsumls-concept:C0001413lld:lifeskim
pubmed-article:11754592lifeskim:mentionsumls-concept:C0041917lld:lifeskim
pubmed-article:11754592lifeskim:mentionsumls-concept:C1418219lld:lifeskim
pubmed-article:11754592lifeskim:mentionsumls-concept:C1418217lld:lifeskim
pubmed-article:11754592lifeskim:mentionsumls-concept:C1418218lld:lifeskim
pubmed-article:11754592lifeskim:mentionsumls-concept:C1418220lld:lifeskim
pubmed-article:11754592lifeskim:mentionsumls-concept:C0390418lld:lifeskim
pubmed-article:11754592lifeskim:mentionsumls-concept:C0026377lld:lifeskim
pubmed-article:11754592lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:11754592lifeskim:mentionsumls-concept:C1260969lld:lifeskim
pubmed-article:11754592lifeskim:mentionsumls-concept:C1554963lld:lifeskim
pubmed-article:11754592lifeskim:mentionsumls-concept:C1709269lld:lifeskim
pubmed-article:11754592lifeskim:mentionsumls-concept:C1656349lld:lifeskim
pubmed-article:11754592pubmed:issue1lld:pubmed
pubmed-article:11754592pubmed:dateCreated2001-12-28lld:pubmed
pubmed-article:11754592pubmed:abstractTextThe potency of nucleotide antagonists at P2Y1 receptors was enhanced by replacing the ribose moiety with a constrained carbocyclic ring (Nandanan, et al. J. Med. Chem. 2000, 43, 829-842). We have now synthesized ring-constrained methanocarba analogues (in which a fused cyclopropane moiety constrains the pseudosugar ring) of adenine and uracil nucleotides, the endogenous activators of P2Y receptors. Methanocarba-adenosine 5'-triphosphate (ATP) was fixed in either a Northern (N) or a Southern (S) conformation, as defined in the pseudorotational cycle. (N)-Methanocarba-uridine was prepared from the 1-amino-pseudosugar ring by treatment with beta-ethoxyacryloyl cyanate and cyclization to form the uracil ring. Phosphorylation was carried out at the 5'-hydroxyl group through a multistep process: Reaction with phosphoramidite followed by oxidation provided the 5'-monophosphates, which then were treated with 1,1'-carbonyldiimidazole for condensation with additional phosphate groups. The ability of the analogues to stimulate phospholipase C through activation of turkey P2Y1 or human P2Y1, P2Y2, P2Y4, P2Y6, and P2Y11 receptors stably expressed in astrocytoma cells was measured. At recombinant human P2Y1 and P2Y2 receptors, (N)-methanocarba-ATP was 138- and 41-fold, respectively, more potent than racemic (S)-methanocarba-ATP as an agonist. (N)-methanocarba-ATP activated P2Y11 receptors with a potency similar to ATP. (N)-Methanocarba-uridine 5'-triphosphate (UTP) was equipotent to UTP as an agonist at human P2Y2 receptors and also activated P2Y4 receptors with an EC(50) of 85 nM. (N)-Methanocarba-uridine 5'-diphosphate (UDP) was inactive at the hP2Y6 receptor. The vascular effects of (N)-methanocarba-UTP and (N)-methanocarba-UDP were studied in a model of the rat mesenteric artery. The triphosphate was more potent than UTP in inducing a dilatory P2Y4 response (pEC(50) = 6.1 +/- 0.2), while the diphosphate was inactive as either an agonist or antagonist in a P2Y6 receptor-mediated contractile response. Our results suggest that new nucleotide agonists may be designed on the basis of the (N) conformation that favors selectivity for P2Y1, P2Y2, P2Y4, and P2Y11 receptors.lld:pubmed
pubmed-article:11754592pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11754592pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11754592pubmed:languageenglld:pubmed
pubmed-article:11754592pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11754592pubmed:citationSubsetIMlld:pubmed
pubmed-article:11754592pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11754592pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11754592pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11754592pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11754592pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11754592pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11754592pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11754592pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11754592pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11754592pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11754592pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11754592pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11754592pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11754592pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11754592pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11754592pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11754592pubmed:statusMEDLINElld:pubmed
pubmed-article:11754592pubmed:monthJanlld:pubmed
pubmed-article:11754592pubmed:issn0022-2623lld:pubmed
pubmed-article:11754592pubmed:authorpubmed-author:MarquezVictor...lld:pubmed
pubmed-article:11754592pubmed:authorpubmed-author:HardenT...lld:pubmed
pubmed-article:11754592pubmed:authorpubmed-author:KimHak SungHSlld:pubmed
pubmed-article:11754592pubmed:authorpubmed-author:RaviR GnanaRGlld:pubmed
pubmed-article:11754592pubmed:authorpubmed-author:MaddiletiSavi...lld:pubmed
pubmed-article:11754592pubmed:authorpubmed-author:WihlborgAnna-...lld:pubmed
pubmed-article:11754592pubmed:authorpubmed-author:ErlingeDavidDlld:pubmed
pubmed-article:11754592pubmed:authorpubmed-author:MalmsjöMalinMlld:pubmed
pubmed-article:11754592pubmed:authorpubmed-author:BoyerJosé LJLlld:pubmed
pubmed-article:11754592pubmed:authorpubmed-author:JacobsonKenne...lld:pubmed
pubmed-article:11754592pubmed:issnTypePrintlld:pubmed
pubmed-article:11754592pubmed:day3lld:pubmed
pubmed-article:11754592pubmed:volume45lld:pubmed
pubmed-article:11754592pubmed:ownerNLMlld:pubmed
pubmed-article:11754592pubmed:authorsCompleteYlld:pubmed
pubmed-article:11754592pubmed:pagination208-18lld:pubmed
pubmed-article:11754592pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:11754592pubmed:meshHeadingpubmed-meshheading:11754592...lld:pubmed
pubmed-article:11754592pubmed:meshHeadingpubmed-meshheading:11754592...lld:pubmed
pubmed-article:11754592pubmed:meshHeadingpubmed-meshheading:11754592...lld:pubmed
pubmed-article:11754592pubmed:meshHeadingpubmed-meshheading:11754592...lld:pubmed
pubmed-article:11754592pubmed:meshHeadingpubmed-meshheading:11754592...lld:pubmed
pubmed-article:11754592pubmed:meshHeadingpubmed-meshheading:11754592...lld:pubmed
pubmed-article:11754592pubmed:meshHeadingpubmed-meshheading:11754592...lld:pubmed
pubmed-article:11754592pubmed:meshHeadingpubmed-meshheading:11754592...lld:pubmed
pubmed-article:11754592pubmed:meshHeadingpubmed-meshheading:11754592...lld:pubmed
pubmed-article:11754592pubmed:meshHeadingpubmed-meshheading:11754592...lld:pubmed
pubmed-article:11754592pubmed:meshHeadingpubmed-meshheading:11754592...lld:pubmed
pubmed-article:11754592pubmed:meshHeadingpubmed-meshheading:11754592...lld:pubmed
pubmed-article:11754592pubmed:meshHeadingpubmed-meshheading:11754592...lld:pubmed
pubmed-article:11754592pubmed:meshHeadingpubmed-meshheading:11754592...lld:pubmed
pubmed-article:11754592pubmed:meshHeadingpubmed-meshheading:11754592...lld:pubmed
pubmed-article:11754592pubmed:meshHeadingpubmed-meshheading:11754592...lld:pubmed
pubmed-article:11754592pubmed:meshHeadingpubmed-meshheading:11754592...lld:pubmed
pubmed-article:11754592pubmed:meshHeadingpubmed-meshheading:11754592...lld:pubmed
pubmed-article:11754592pubmed:year2002lld:pubmed
pubmed-article:11754592pubmed:articleTitleMethanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.lld:pubmed
pubmed-article:11754592pubmed:affiliationMolecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-0810, USA.lld:pubmed
pubmed-article:11754592pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11754592pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:11754592pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11754592pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:11754592lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11754592lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11754592lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11754592lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11754592lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11754592lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11754592lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11754592lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11754592lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11754592lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11754592lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11754592lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11754592lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11754592lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11754592lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11754592lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11754592lld:pubmed